Research suggests that certain obesity drugs, including GLP-1 medications, may have a positive effect on addiction by reducing its underlying drivers. These drugs, which have been successful for weight loss, are being studied for their potential to prevent or treat multiple addictions. The exact nature and duration of this effect is still being explored, with some studies indicating a potential temporary impact on brain activity related to cravings.